ARS Pharmaceuticals Target Price

See how SPRY's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.1

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-04-09	Northland Securities	$25	309.8% upside
2026-03-10	Leerink PartnersRoanna Ruiz	$26	326.2% upside
2025-11-04	Roth CapitalKyle Bauser	$30	391.8% upside
2025-09-26	Raymond James	$32	424.6% upside
2024-08-19	Cantor FitzgeraldJosh Schimmer	$30	391.8% upside
2024-08-12	Raymond JamesStrong Buy	$22	260.7% upside
2024-07-25	Raymond JamesRyan Deschner	$18	195.1% upside
2024-03-05	Leerink PartnersRoanna Ruiz	$18	195.1% upside
2022-12-13	Leerink Partners	$14	129.5% upside

ARS Pharmaceuticals (SPRY) FAQ

Stockcircle tracks target price for ARS Pharmaceuticals (SPRY), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for ARS Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main SPRY overview so you can move from this figure to the surrounding analysis quickly.